Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $9.2 Million - $12.3 Million
-100,000 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $6.98 Million - $8.92 Million
100,000
100,000 $8.89 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mork Capital Management, LLC Portfolio

Follow Mork Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mork Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mork Capital Management, LLC with notifications on news.